GlassScriptPhysician profile
Stephen R Soffer
NPI 1962450536
$5,761.07
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $1,248 · 2021: $1,737 · 2022: $1,928 · 2023: $38.71 · 2024: $39.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.44 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.44 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $3,449.04 | 2021-2022 | |
| Arthrex, INC. | $1,699.01 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $155.51 | 2022 | |
| Pacira Therapeutics, INC. | $91.14 | 2019 | |
| Djo, LLC | $47.76 | 2021 | |
| Bioventus LLC | $46.95 | 2019 | |
| Davol INC. | $39.44 | 2024 | Arista Ah Flexitip |
| Baxter Healthcare | $38.71 | 2023 | |
| Depuy Synthes Sales INC. | $36.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.75 | 2019 | |
| Arteriocyte Medical Systems, INC. | $24.10 | 2019 | |
| Boston Scientific Corporation | $18.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.28 | 2020 | |
| Zyla Life Sciences, INC. | $14.94 | 2020 | |
| Fx Shoulder Solutions, INC | $13.24 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $12.61 | 2019 | |
| Conmed Corporation | $12.00 | 2022 | |
| Pfizer INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Soffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.